Evidence map›Paper›PMID 27995345›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2017

Interpretation of the Elecsys Toxo IgG avidity results for very low and very high index: study on 741 sera with a determined date of toxoplasmosis.

H Fricker-Hidalgo, C L'Ollivier, C Bosson, S Imbert, S Bailly, C Dard, R Piarroux, L Paris, H Pelloux

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Article
  3. Interpretation of very low avidity indices acquired with the Liaison XL Toxo IgG avidity assay in dating toxoplasmosis infection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

H Fricker-HidalgoLaboratory of Parasitology and Mycology, Grenoble University Hospital and Grenoble Alpes University, CS10217, 38043, Grenoble Cedex 9, France. hfricker-hidalgo@chu-grenoble.fr.ORCID http://orcid.org/0000-0002-1932-2531
C L'OllivierLaboratory of Parasitology and Mycology, La Timone University Hospital and UMR MD3 IP-TPT Aix Marseille University, Marseille, France.
C BossonLaboratory of Parasitology and Mycology, Grenoble University Hospital and Grenoble Alpes University, CS10217, 38043, Grenoble Cedex 9, France.
S ImbertLaboratory of Parasitology and Mycology, AP-HP, Pitié Salpêtrière/Charles Foix University Hospital, Paris, France.
S BaillyLaboratory of Parasitology and Mycology, Grenoble University Hospital and Grenoble Alpes University, CS10217, 38043, Grenoble Cedex 9, France.
C DardLaboratory of Parasitology and Mycology, Grenoble University Hospital and Grenoble Alpes University, CS10217, 38043, Grenoble Cedex 9, France.
R PiarrouxLaboratory of Parasitology and Mycology, La Timone University Hospital and UMR MD3 IP-TPT Aix Marseille University, Marseille, France.
L ParisLaboratory of Parasitology and Mycology, AP-HP, Pitié Salpêtrière/Charles Foix University Hospital, Paris, France.
H PellouxLaboratory of Parasitology and Mycology, Grenoble University Hospital and Grenoble Alpes University, CS10217, 38043, Grenoble Cedex 9, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Initial results with the Elecsys Toxo IgG Avidity assay showed some potential for interpretation of a very low or very high index result. We aimed to examine these new insights into interpretation using a large panel of serum samples and to define the optimal thresholds. A total of 741 patient serum samples with known date of infection (from a few weeks to more than 9 months after infection), were analysed with the Elecsys Toxo IgG Avidity assay. Values ≥80% (threshold defined by the manufacturer) were reported in 289 sera; 288 sera were sampled more than 4 months after infection. Thus, avidity values ≥80% excluded an infection less than 4 months. Avidity values ≥90% were reported in 112 sera sampled more than 9 months after infection. Thus, avidity values ≥90% excluded infection less than 9 months. Moreover avidity values ≤15% were reported in the 62 sera sampled less than 3 months after infection. Thus avidity values ≤15% excluded infection more than 3 months.

Indexed as

Antibody AffinityAntibodies, ProtozoanFemaleHumansImmunoassayImmunoglobulin GPregnancyTime FactorsToxoplasmosisAntibodies, ProtozoanImmunoglobulin G

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.